Keneric Healthcare (formerly GWM Products, LLC), manufacturer and distributor of RTD® Wound Dressing, announced today that the key claim in the Hydrofera '764 patent has been rejected for the second time in a Final Office Action by the Patent & Trademark Office (PTO). This Reexamination Proceeding was initiated (by Keneric Healthcare) in response to the '764 patent infringement case filed against Keneric Healthcare by Hydrofera, LLC, a subsidiary of Hollister, Inc., in November 2013. The rejected claim is the only claim involved in the ongoing '764 patent infringement case filed by Hydrofera, LLC. "The PTO's repeated rejection substantiates our continuing belief that the '764 patent is invalid," Keneric Healthcare’s President Dr. Jean Achterberg said. If this rejection is not overcome, the patent claim asserted against the Company in the Hydrofera litigation will be invalidated, and Keneric Healthcare will then prevail in its litigation.
About Keneric Healthcare
Based in Irving, Texas, Keneric Healthcare manufactures and distributes RTD®, a line of advanced wound care products. RTD® is the only dressing that combines the antimicrobial and antifungal properties of methylene blue and gentian violet with the added benefits of silver. Keneric Healthcare provides innovative wound care products that address the multiple priorities of wound healing while supporting the economic and time-saving needs of healthcare providers. RTD® is FDA cleared and is indicated for the treatment of partial to full thickness wounds with moderate to heavy exudate. RTD® is available in various sizes and thicknesses.
To learn more, please go to www.KenericHealthcare.com
Contact: Al Henry, CEO of Keneric Healthcare: 1-855-872-2013
Help employers find you! Check out all the jobs and post your resume.
About Keneric Healthcare
Based in Irving, Texas, Keneric Healthcare manufactures and distributes RTD®, a line of advanced wound care products. RTD® is the only dressing that combines the antimicrobial and antifungal properties of methylene blue and gentian violet with the added benefits of silver. Keneric Healthcare provides innovative wound care products that address the multiple priorities of wound healing while supporting the economic and time-saving needs of healthcare providers. RTD® is FDA cleared and is indicated for the treatment of partial to full thickness wounds with moderate to heavy exudate. RTD® is available in various sizes and thicknesses.
To learn more, please go to www.KenericHealthcare.com
Contact: Al Henry, CEO of Keneric Healthcare: 1-855-872-2013
Help employers find you! Check out all the jobs and post your resume.
